Method for preparing a physiologically active IL-18 polypeptide

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S069520, C530S351000

Reexamination Certificate

active

07442526

ABSTRACT:
The present invention provides a method for producing physiologically active human Interleukin-18 (“IL-18”).

REFERENCES:
patent: 5914254 (1999-06-01), Mascarenhas et al.
patent: 5985863 (1999-11-01), Su et al.
patent: 6054487 (2000-04-01), Sekut et al.
patent: 0921005 (1998-01-01), None
Sequence search results: sequence alignment between SEQ ID No. 4 of the present application and the sequence of Figure 1A of Munday et al., J. Biol. Chem., 1995, 270(26):15870-76.
Fassay, et al., “Enzymatic Activity of Two Caspases Related to Interleukin-1beta-Converting Enzyme,”Eur. J. Biochem.,253(1): 76-83 (1998).
Garcia-Calvo, et al., “Purification and Catalytic Properties of Human Caspase Family Members,”Cell Death and Diff.,6(4): 362-369 (1999).
Ghayur, et al., “Caspase-1 Processes IFN-Gamma-Inducing Factor and Regulates LPS-Induced IFN-Gamma Production,”Nature,389: 619-623 (1997).
Munday, et al., “Molecular Cloning and Pro-Apoptotic Activity of ICErelII and ICErelIII, Memebers of the ICE/CED-3 Family of Cysteine Proteases,”J. Biol. Chem.,270: 15870-15876 (1995).
Ushio, et al., “Cloning of the cDNA for Human IFN-Gamma-Inducing Factor, Expression inEscherichia coli, and Studies on the Biologic Activities of the Protein,”J. Immunol.,156: 4274-4279 (1996).
Howard, et al., “Human IL-1-beta Processing and Secretion in Recombinant Baculovirus-Infected Sf9 Cells is Blocked by the Cowpox Virus Serpin crmA,”Journal of Immunology,154(5), pp. 2321-2332, (1995).
Hsieh, et al., “Improved Gene Expression by a Modified Bicistronic Retroviral Vector,”Biochemical and Biophysical Research Communications, 214(3), pp. 910-917, (1995).
Muneta, et al., “Efficient Production of Biologically Active Porcine Interleukin-18 by Coexpression with Porcine Caspase-1 Using a Baculovirus Expression System,”Journal of Interferon and Cytokine Research, 21(2), pp. 125-130, (2001).
Hildinger, et al., “Bicistronic Retroviral Vectors for Combining Myeloprotection with Cell-surface Marking,”Gene Therapy,6(7), pp. 1222-1230, (1999).
Harris, et al., “A New Baculovirus Expression Vector for the Simultaneous Expression of Two Heterologous Proteins in the Same Insect Cell,”Focus,19(1), pp. 10-12, (1996).
Dang, et al., “Preparation of an Autolysis-resistant IL-1b Converting Enzyme Mutant,”Biochemistry,35:149, pp. 14910-14916, (1996).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for preparing a physiologically active IL-18 polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for preparing a physiologically active IL-18 polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preparing a physiologically active IL-18 polypeptide will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4018865

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.